Theory and Modeling of Biomolecules and their Interactions
生物分子及其相互作用的理论和建模
基本信息
- 批准号:10094219
- 负责人:
- 金额:$ 83.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsActin-Binding ProteinAddressAreaBig DataBiologicalBiomedical ResearchCREBBP geneChemicalsCollaborationsCommunitiesComplexComputer SimulationComputer softwareComputing MethodologiesDevelopmentDockingEnvironmentEnzymesEquilibriumEvolutionFibroblast Growth FactorFlavinsFree EnergyGTP-Binding ProteinsGenetic TranscriptionGoalsHRX proteinInterleukinsLigand BindingLigandsMED25 geneMalignant NeoplasmsMediatingMediationMeninMethodologyMethodsMixed Function OxygenasesModelingMolecularNucleic AcidsOncogenicPharmaceutical PreparationsPharmacologic SubstancePhosphotransferasesPlayProcessProteinsProtocols documentationResearchRoleSignal TransductionStatistical MechanicsStatistical MethodsStructureTechnologyTestingThermodynamicsTranscriptional ActivationWorkbasecancer therapydesigninhibitor/antagonistinnovationinsightmodels and simulationmolecular dynamicsnovelprotein protein interactionprotonationreceptorsensorsimulationsmall moleculesoftware developmentsoftware infrastructuretheoriestool
项目摘要
Project Summary/Abstract
The establishment of tools and methods from statistical mechanics and computer simulation technology to
enable the exploration of biological molecules and their interactions plays a central role in discovery within
biomedical research. This proposal represents a request for support of our ongoing efforts in this area and
includes objectives to address challenges in the theory and modeling associated with these problems, as well
as strategically chosen collaborations that will help elucidate important biomedical questions and provide crucial
tests of the approaches we develop. Our proposed development efforts include the exploration of receptor-ligand
interactions and the thermodynamics of ligand binding to biological receptors through the continued development
and application of novel methods of free energy simulations to ligand binding thermodynamics, docking and
receptor-ligand interaction modeling. The continued refinement, hardening and application of theoretical and
computational methods of constant pH molecular dynamics to integrate the critical aspects of pH and protonation
state changes in protein and nucleic acid receptors and their ligands in molecular simulations and modeling
represents another challenge we will continue to address with the proposed work. Finally, software
infrastructure, specifically the CHARMM macromolecular simulation package, provides the framework for
advancing our methodological approaches and enabling the broader community to explore biomedically
motivated questions via its wide usage and distribution. A component of our proposed efforts will be to continue
the innovative implementation of methods and simulation approaches into this community standard software
package. We will balance and drive our development efforts in the areas of free energy simulations, ligand –
receptor docking and pH-mediated structure-function processes, important to a deeper mechanistic
understanding of biomedically directed questions, through strategic collaborations with experimental colleagues
in the areas of: transcriptional activation based on small amphipathic molecules targeting co-activators from the
CREB binding protein (KIX) and the AciD domain of Med25; key cancer targets such as menin-MLL protein-
protein interaction inhibition; inhibitors of acyl protein thioesterases, targeted in anti-cancer therapies for
oncogenic HRas; enzyme redesign and substrate scope expansion to better understand the evolution of function
of a novel Flavin-dependent hydroxylase in exploiting complex chemical transformations important in the
development of pharmaceuticals; pH-regulated sensors in kinase signaling associated with the G-protein from
the tetrameric Gai protein; the pH-modulated switch for myristoylated histactophilin, the actin binding protein that
is structurally homologous with interleukin-1b and fibroblast growth factor. Finally, we will engage experts in the
development of big data applications of molecular simulations and the design and execution of robust user APIs
to work with us toward advancing objectives in software development for large multi-scale simulations of cellular
environments and automated workflows, through CHARMM-GUI, for sophisticated simulation protocols.
项目概要/摘要
从统计力学和计算机模拟技术出发建立工具和方法
使生物分子及其相互作用的探索在发现中发挥着核心作用
该提案代表了对我们在该领域持续努力的支持的请求。
包括解决与这些问题相关的理论和建模挑战的目标,以及
作为战略选择的合作,将有助于阐明重要的生物医学问题并提供关键的
我们开发的方法的测试包括对受体配体的探索。
通过持续发展,配体与生物受体结合的相互作用和热力学
以及自由能模拟新方法在配体结合热力学、对接和应用中的应用
受体-配体相互作用模型的不断完善、强化和应用。
恒定 pH 分子动力学的计算方法,整合 pH 和质子化的关键方面
分子模拟和建模中蛋白质和核酸受体及其配体的状态变化
这是我们将继续通过拟议工作解决的另一个挑战。最后,软件。
基础设施,特别是 CHARMM 大分子模拟软件包,提供了框架
推进我们的方法论并使更广泛的社区能够探索生物医学
我们提议的努力的一个组成部分将是继续通过其广泛使用和分发来激发问题。
将方法和模拟方法创新地实施到该社区标准软件中
我们将平衡并推动我们在自由能模拟、配体领域的开发工作。
受体对接和 pH 介导的结构功能过程,对于更深层次的机制很重要
通过与实验同事的战略合作来理解生物医学导向的问题
在以下领域:基于小两亲分子的转录激活,靶向来自
CREB 结合蛋白 (KIX) 和 Med25 的 AciD 结构域,例如 menin-MLL 蛋白 -
蛋白质相互作用抑制;酰基蛋白硫酯酶抑制剂,针对癌症治疗
致癌 HRas;酶重新设计和底物范围扩展,以更好地了解功能的进化
一种新型黄素依赖性羟化酶在利用复杂的化学转化方面具有重要意义
开发与 G 蛋白相关的激酶信号传导中的 pH 调节传感器
四聚体 Gai 蛋白;肉豆蔻酰化亲组织蛋白(肌动蛋白结合蛋白)的 pH 调节开关
与白细胞介素 1b 和成纤维细胞生长因子在结构上同源。最后,我们将聘请该领域的专家。
分子模拟大数据应用的开发以及强大的用户 API 的设计和执行
与我们合作,推进大规模多尺度细胞模拟软件开发目标
通过 CHARMM-GUI 实现复杂的模拟协议的环境和自动化工作流程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES L BROOKS其他文献
CHARLES L BROOKS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES L BROOKS', 18)}}的其他基金
Theory and Modeling of Biomolecules and their Interactions - Equipment Supplement
生物分子及其相互作用的理论和建模 - 设备补充
- 批准号:
9894101 - 财政年份:2019
- 资助金额:
$ 83.16万 - 项目类别:
Theory and Modeling of Biomolecules and their Interactions - Equipment Supplement
生物分子及其相互作用的理论和建模 - 设备补充
- 批准号:
10580491 - 财政年份:2019
- 资助金额:
$ 83.16万 - 项目类别:
Theory and Modeling of Biomolecules and their Interactions
生物分子及其相互作用的理论和建模
- 批准号:
10554419 - 财政年份:2019
- 资助金额:
$ 83.16万 - 项目类别:
Theory and Modeling of Biomolecules and their Interactions
生物分子及其相互作用的理论和建模
- 批准号:
10333335 - 财政年份:2019
- 资助金额:
$ 83.16万 - 项目类别:
Acid-mediated processes in nucleic acids and proteins
核酸和蛋白质中酸介导的过程
- 批准号:
8854117 - 财政年份:2014
- 资助金额:
$ 83.16万 - 项目类别:
Acid-mediated processes in nucleic acids and proteins
核酸和蛋白质中酸介导的过程
- 批准号:
9068970 - 财政年份:2014
- 资助金额:
$ 83.16万 - 项目类别:
Acid-mediated processes in nucleic acids and proteins
核酸和蛋白质中酸介导的过程
- 批准号:
8691310 - 财政年份:2014
- 资助金额:
$ 83.16万 - 项目类别:
Acid-mediated processes in nucleic acids and proteins
核酸和蛋白质中酸介导的过程
- 批准号:
9294086 - 财政年份:2014
- 资助金额:
$ 83.16万 - 项目类别:
CORE 2006-2011: COMPUTATIONAL IMPLEMENTATION OF A TIME CORRELATION FUNCTION THE
CORE 2006-2011:时间相关函数的计算实现
- 批准号:
8364273 - 财政年份:2011
- 资助金额:
$ 83.16万 - 项目类别:
相似国自然基金
肌动蛋白结合蛋白Xirp2介导基质刚度诱导心肌细胞肥大的力学生物学机制
- 批准号:12372314
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
肌动蛋白结合蛋白ANLN在胆汁淤积性肝损伤后肝再生过程中的作用及机制研究
- 批准号:82370648
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肌动蛋白结合蛋白2降调通过Rap1信号通路参与子痫前期发病的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
转录因子Pax5调控肌动蛋白结合蛋白诱导线粒体凋亡在神经管畸形发生过程中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Cortactin在紫绀型先心病内源性肺保护中的作用及机制研究
- 批准号:81870070
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating the Mechanistic Basis for Phagotrophy in the Protozoan Trypansoma cruzi
阐明原生动物克氏锥虫吞噬作用的机制基础
- 批准号:
10345248 - 财政年份:2022
- 资助金额:
$ 83.16万 - 项目类别:
Structure-based targeting of the C. difficile toxin (CDT) from hypervirulent bacterial strains
基于结构的高毒力细菌菌株中艰难梭菌毒素 (CDT) 的靶向
- 批准号:
10455150 - 财政年份:2021
- 资助金额:
$ 83.16万 - 项目类别: